AVBCC Value-Based Voices
The Association for Value-Based Cancer Care’s (AVBCC) podcast series addresses the ever-evolving
landscape of value related to cancer care in the United States. Our goal is to foster informed dialogue, promote transparency, and empower all players to navigate the rapidly changing landscape of cancer care with clarity and confidence.
Episodes
7 episodes
From the Human Genome Project to 48 Hours: The Rapid Evolution of Tumor Biology
Most treatments and diagnostics once took years and hundreds of millions of dollars. Today, it costs less than $100,000 to sequence a genome and open the door to tailored cancer therapies that could save lives. But understanding tumor biology i...
Navigating Value and Policy in U.S. Cancer Care and Pharma Pricing
International reference pricing could drastically reshape drug costs in the U.S. and threaten domestic innovation. In this latest episode of AVBCC’s Value-Based Voices, join Jayson Slotnik, JD, MPH, Partner, Health Policy Strategies, Inc., and ...
Most Favored Nation and What's Next
Most companies, and even policymakers, are betting big on importing international drug prices — but what does that really mean for cancer care in America? In this episode of Value-Based Voices, Jayson Slotnik, JD, MPH, ...
AI Revolution: Breaking Pharmacy Chains with Harry Travis, BS Pharm, MBA, and Ira Klein, MD, MBA, FACP
There are countless opportunities hidden in the data-driven tasks pharmacists do every day, and AI is ready to unlock them. But what happens when automation dramatically increases productivity in pharmacy, and how do regulations, workforce, and...
Consolidation Versus Independence in Cancer Care
Is consolidation in cancer care truly the best path forward, or does independence offer greater benefits?In this episode of Value-Based Voices Sarah Alwardt, PhD, President, ...
Insights from JP Morgan 2026 with Liz Fowler, PhD, JD
Commercial health plans may have been missing from J.P. Morgan 2026, but government had a big presence! Value-Based Voices host Burt Zweigenhaft, PhD, and nationally recognized health policy expert Liz Fowler, PhD, JD, share their observations ...
More Insights from JP Morgan 2026 with Jeff Berkowitz, JD
Where was the drama at JP Morgan this year? Host Burt Zweigenhaft, PhD, and seasoned healthcare executive Jeff Berkowitz, JD, debate why the 2026 meeting seemed to be missing its normal electricity. They also share their thoughts around challen...